Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin

Annals of Pharmacotherapy

Volumn 41, Issue 4, 2007, Pages 696-701

  Cobb, Elizabeth ^a   Kimbrough, Robert C ^a   Nugent, Kenneth M ^a   Phy, Michael P ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Daptomycin; Organizing pneumonia

Indexed keywords

DAPTOMYCIN;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG ACCUMULATION; DRUG TOLERABILITY; HUMAN; KNEE PROSTHESIS; LOEFFLER PNEUMONIA; LONG TERM EXPOSURE; LUNG ALVEOLUS EPITHELIUM; LUNG INFILTRATE; LUNG NODULE; MALE; MEDIASTINUM LYMPH NODE; NEEDLE BIOPSY; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; PROSTHESIS INFECTION; SKIN INFECTION;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; EOSINOPHILIA; HUMANS; MALE; PNEUMONIA;

EID: 34247247131     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H372     Document Type: Article

References (13)

1. Package insert. Cubicin (daptomycin). Lexington, MA: Cubist Pharmaceuticals, May 2006.
2. Arbeit RD, Maki D, Tally FP, et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004;38:1673-81.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Oleson FB, Berman CL, Kirkpatrick JB, et al. Once-daily dosing in dogs optimizes daptomycin safety. Antimicrob Agents Chemother 2000,44: 2948-53.
5. Camus PH, Foucher P, Bonniaud PH, Ask K. Drug-induced infiltrative lung disease. Eur Respir J Suppl 2001;32(Suppl):93s-100s.
6. Flieder DB, Travis WD. Pathologic characteristics of drug-induced lung disease. Clin Chest Med 2004;25:37-45.
7. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000;20:1245-59.
8. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001;161:158-64.
9. Cordier JF. Organising pneumonia. Thorax 2000;55:318-28.
10. Epler GR. Drug-induced bronchiolitis obliterans organizing pneumonia. Clin Chest Med 2004;25:89-94.
11. Allen JN. Drug-induced eosinophilic lung disease. Clin Chest Med 2004;25:77-88.
12. Jung D, Rozek A, Okon M, et al. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chemistry & Biology 2004;11:949-57.
13. Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 2005;191:2149-52.